105 related articles for article (PubMed ID: 10880736)
1. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
Minguela A; Marín L; Torío A; Muro M; García-Alonso AM; Moya-Quiles MR; Sánchez-Bueno F; Parrilla P; Alvarez-López MR
Hum Immunol; 2000 Jul; 61(7):658-69. PubMed ID: 10880736
[TBL] [Abstract][Full Text] [Related]
2. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
[TBL] [Abstract][Full Text] [Related]
3. B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge.
Zheng P; Wu Y; Guo Y; Lee C; Liu Y
Proc Natl Acad Sci U S A; 1998 May; 95(11):6284-9. PubMed ID: 9600957
[TBL] [Abstract][Full Text] [Related]
4. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).
Mandelbrot DA; McAdam AJ; Sharpe AH
J Exp Med; 1999 Jan; 189(2):435-40. PubMed ID: 9892625
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation.
Denton MD; Geehan CS; Alexander SI; Sayegh MH; Briscoe DM
J Exp Med; 1999 Aug; 190(4):555-66. PubMed ID: 10449526
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4 blockade augments human T lymphocyte-mediated suppression of lung tumor xenografts in SCID mice.
Sabel MS; Hess SD; Egilmez NK; Conway TF; Chen FA; Bankert RB
Cancer Immunol Immunother; 2005 Oct; 54(10):944-52. PubMed ID: 15846492
[TBL] [Abstract][Full Text] [Related]
7. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells.
Eck SC; Turka LA
Cancer Immunol Immunother; 1999 Sep; 48(6):336-41. PubMed ID: 10473809
[TBL] [Abstract][Full Text] [Related]
8. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics.
van der Merwe PA; Bodian DL; Daenke S; Linsley P; Davis SJ
J Exp Med; 1997 Feb; 185(3):393-403. PubMed ID: 9053440
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response.
McGaha T; Murphy JW
Infect Immun; 2000 Aug; 68(8):4624-30. PubMed ID: 10899865
[TBL] [Abstract][Full Text] [Related]
10. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.
Qureshi OS; Zheng Y; Nakamura K; Attridge K; Manzotti C; Schmidt EM; Baker J; Jeffery LE; Kaur S; Briggs Z; Hou TZ; Futter CE; Anderson G; Walker LS; Sansom DM
Science; 2011 Apr; 332(6029):600-3. PubMed ID: 21474713
[TBL] [Abstract][Full Text] [Related]
11. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
Viglietta V; Kent SC; Orban T; Hafler DA
J Clin Invest; 2002 Apr; 109(7):895-903. PubMed ID: 11927616
[TBL] [Abstract][Full Text] [Related]
12. CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis.
Xu X; Dennett P; Zhang J; Sherrard A; Zhao Y; Masubuchi T; Bui JD; Chen X; Hui E
J Exp Med; 2023 Jul; 220(7):. PubMed ID: 37042938
[TBL] [Abstract][Full Text] [Related]
13. CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68.
Fuse S; Obar JJ; Bellfy S; Leung EK; Zhang W; Usherwood EJ
J Virol; 2006 Sep; 80(18):9159-70. PubMed ID: 16940527
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis.
Steiner K; Moosig F; Csernok E; Selleng K; Gross WL; Fleischer B; Bröker BM
Clin Exp Immunol; 2001 Oct; 126(1):143-50. PubMed ID: 11678911
[TBL] [Abstract][Full Text] [Related]
15. B7-2 expression on tumor cells is important for the acquisition of cytotoxic T lymphocyte activity by spleen cells from low-dose-melphalan-treated MOPC-315 tumor bearers via a mechanism that requires either B7-1 or B7-2 expression on host antigen-presenting cells.
Sojka DK; La Motte RN; Mokyr MB
Cancer Immunol Immunother; 2000 Apr; 49(1):10-22. PubMed ID: 10782862
[TBL] [Abstract][Full Text] [Related]
16. Co-stimulatory pathway competitive assay development using Liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Malkawi AK; Ohlund L; Rahman AMA; Sleno L; Siaj M
J Pharm Biomed Anal; 2024 May; 242():116034. PubMed ID: 38422671
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.
Bour-Jordan H; Esensten JH; Martinez-Llordella M; Penaranda C; Stumpf M; Bluestone JA
Immunol Rev; 2011 May; 241(1):180-205. PubMed ID: 21488898
[TBL] [Abstract][Full Text] [Related]
18. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.
Bluestone JA; Liu W; Yabu JM; Laszik ZG; Putnam A; Belingheri M; Gross DM; Townsend RM; Vincenti F
Am J Transplant; 2008 Oct; 8(10):2086-96. PubMed ID: 18828769
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD80/CD86 and CTLA-4 mRNA in peripheral blood mononuclear cells of the patients with systemic lupus erythematosus.
Liu W; Li J
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(3):247-9. PubMed ID: 15315339
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood antigen-presenting cells from African-Americans exhibit increased CD80 and CD86 expression.
Hutchings A; Purcell WM; Benfield MR
Clin Exp Immunol; 1999 Nov; 118(2):247-52. PubMed ID: 10540186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
